Aprea Therapeutics

$5.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.53 (-9.64%) Today

+$0.03 (+0.60%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell APRE and other stocks, options, and ETFs commission-free!

About APRE

Aprea Therapeutics, Inc. Common stock, also called Aprea Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the provision of cancer therapeutics.

CEO

Christian S. Schade

Employees

—

Headquarters

Boston, Massachusetts

Founded

2002

Market Cap

95.34M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.88M

High Today

$5.41

Low Today

$4.93

Open Price

$5.31

Volume

1.85M

52 Week High

$41.12

52 Week Low

$4.64

Analyst Ratings

17%

of 6 ratings

Buy

17%

Hold

83%

Sell

APRE Earnings

-$5.29

-$3.53

-$1.76

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 14, After Hours